Telegram VKontakte Yandex Youtube

Latest news

News

Chinese scientists successfully test gene therapy for hereditary high cholesterol

A group of Chinese researchers led by Professor Xia Qiang of Shanghai Jiao Tong University has completed Phase I clinical trials of an experimental...
News

Ministry of Health updates clinical guidelines for the treatment of type 1 diabetes in adults

The Ministry of Health has updated the clinical guidelines for the treatment of type 1 diabetes mellitus in adults, according to data published on...
News

Droplet Biosciences accelerates post-surgical cancer detection with AI

American diagnostic startup Droplet Biosciences has announced a collaboration with technology giant NVIDIA. As part of the partnership, the company will use NVIDIA's artificial...
News

Novo Nordisk to invest $507 million in Ireland Plant for Wegovy Production

Danish pharma giant Novo Nordisk has announced it will invest €432 million (approximately $507 million) to upgrade its Irish facility to produce its blockbuster...
Events

Ministry of Industry and Trade reports on production of platinum-based cancer drugs

The Russian Ministry of Industry and Trade stated that the production volume of essential platinum-based anticancer drugs (carboplatin, oxaliplatin, and cisplatin) in January–February 2026...
News

US approves drug to treat children with dwarfism

The U.S. Food and Drug Administration (FDA) has approved the drug Yuviwel (navepegritide) from the global biopharmaceutical company Ascendis Pharma for the treatment of...
News

Botulinum toxin sales in Russia reach 10-year high

The Russian healthcare system received 1.66 million packages of botulinum toxin-based drugs in 2025. As GxP News was informed by the analytical company RNC...
News

First combined COVID-19 and flu vaccine set for EU market

European drug regulators have recommended granting a marketing authorization for Moderna's combination flu and COVID-19 vaccine. The shot, dubbed mCombriax, is an mRNA-based vaccine...

Most popular

«GxP News» — зарегистрированный товарный знак. Использование названия на латинице осуществляется на основании свидетельства Роспатента № 920870 от 03.02.2023 г. в соответствии с п. 3 ст. 3 Федерального закона от 01.06.2005 № 53-ФЗ «О государственном языке Российской Федерации». Все права защищены. © 2019–2026 ООО «Медиа-Фарм Новости».

Воспроизведение материалов допускается только при соблюдении ограничений, установленных правообладателем, при указании автора используемых материалов и ссылки на портал GxP News как на источник заимствования.

18+

WordPress Ads